← Browse by Condition
Medical Condition

neuroblastoma metastatic

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05296564 Phase 1, Phase 2
Recruiting

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Enrollment
3 pts
Location
Israel
Sponsor
Hadassah Medical Organization
View Trial →